FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025183670> ?p ?o ?g. }

• W2025183670 endingPage "175" @default.
• W2025183670 startingPage "167" @default.
• W2025183670 abstract "Introduction: Sedation with dexmedetomidine may facilitate ventilator liberation and limit the occurrence of delirium. No trial has assessed patient recall or the development of psychological outcomes after dexmedetomidine sedation. This pilot study evaluated whether transitioning benzodiazepine sedation to dexmedetomidine alters patient recall and the incidence of anxiety, depression, or acute stress disorder (ASD). Methods: This investigation was a randomized, double-blind, single-center study. Existing continuous benzodiazepine sedation was converted to dexmedetomidine or midazolam when patients qualified for daily awakenings. Sedation was titrated to achieve Riker sedation agitation scores of 3 to 4. The intensive care unit (ICU) Stressful Experiences Questionnaire, hospital anxiety and depression scale, and the impact of event scale-revised were administered before hospital discharge to assess recall, anxiety, depression, and manifestations of ASD. Results: A total of 11 patients received dexmedetomidine, and 12 patients received midazolam. Median dosing was 0.61 µg/kg/h for 3.5 days for dexmedetomidine and 3.7 mg/h for 3 days for midazolam. Attainment of goal sedation and analgesia was similar; however, more dexmedetomidine patients experienced agitation and pain. The median duration of mechanical ventilation from study drug initiation to extubation was 3.4 days in dexmedetomidine patients and 2.9 days in midazolam patients. Dexmedetomidine patients remembered 18.5 experiences compared with 8.5 in midazolam patients ( P = .015). Rates of anxiety and depression were similar. In all, 5 (62.5%) dexmedetomidine patients and 1 (12.5%) midazolam patient manifested ASD ( P = .063), and 1 dexmedetomidine patient and 5 midazolam patients developed new-onset delirium ( P = .07). Hypotension occurred in 10 (90.9%) dexmedotomidine patients and 6 (50%) midazolam patients ( P = .069). Conclusions: Transitioning benzodiazepine sedation to dexmedetomidine when patients qualify for daily awakenings may reduce the development of delirium and facilitate remembrance of ICU experiences but may lead to manifestations of ASD. Monitoring hypotension is required for both the sedatives. Additional comparative studies focusing on the long-term impact of ICU recall and psychological outcomes are needed." @default.
• W2025183670 created "2016-06-24" @default.
• W2025183670 creator A5002007061 @default.
• W2025183670 creator A5004784482 @default.
• W2025183670 creator A5040757935 @default.
• W2025183670 creator A5075966979 @default.
• W2025183670 creator A5077613549 @default.
• W2025183670 creator A5077824195 @default.
• W2025183670 creator A5082697782 @default.
• W2025183670 date "2013-11-12" @default.
• W2025183670 modified "2023-10-04" @default.
• W2025183670 title "A Randomized, Double-Blind Pilot Study of Dexmedetomidine Versus Midazolam for Intensive Care Unit Sedation" @default.
• W2025183670 cites W1972397607 @default.
• W2025183670 cites W1983668035 @default.
• W2025183670 cites W1988542273 @default.
• W2025183670 cites W1990490014 @default.
• W2025183670 cites W1993222885 @default.
• W2025183670 cites W1993435783 @default.
• W2025183670 cites W1994293948 @default.
• W2025183670 cites W1994796509 @default.
• W2025183670 cites W2002317781 @default.
• W2025183670 cites W2029975787 @default.
• W2025183670 cites W2035254645 @default.
• W2025183670 cites W2050317494 @default.
• W2025183670 cites W2054293687 @default.
• W2025183670 cites W2059214042 @default.
• W2025183670 cites W2061187046 @default.
• W2025183670 cites W2067626759 @default.
• W2025183670 cites W2082311304 @default.
• W2025183670 cites W2087694898 @default.
• W2025183670 cites W2087788300 @default.
• W2025183670 cites W2091416932 @default.
• W2025183670 cites W2092925442 @default.
• W2025183670 cites W2098700447 @default.
• W2025183670 cites W2119530296 @default.
• W2025183670 cites W2127193957 @default.
• W2025183670 cites W2130271602 @default.
• W2025183670 cites W2135672238 @default.
• W2025183670 cites W2138301911 @default.
• W2025183670 cites W2160385789 @default.
• W2025183670 cites W2165942671 @default.
• W2025183670 cites W2167177341 @default.
• W2025183670 doi "https://doi.org/10.1177/0885066613510874" @default.
• W2025183670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24227448" @default.
• W2025183670 hasPublicationYear "2013" @default.
• W2025183670 type Work @default.
• W2025183670 sameAs 2025183670 @default.
• W2025183670 citedByCount "36" @default.
• W2025183670 countsByYear W20251836702014 @default.
• W2025183670 countsByYear W20251836702015 @default.
• W2025183670 countsByYear W20251836702016 @default.
• W2025183670 countsByYear W20251836702017 @default.
• W2025183670 countsByYear W20251836702018 @default.
• W2025183670 countsByYear W20251836702019 @default.
• W2025183670 countsByYear W20251836702020 @default.
• W2025183670 countsByYear W20251836702021 @default.
• W2025183670 countsByYear W20251836702022 @default.
• W2025183670 countsByYear W20251836702023 @default.
• W2025183670 crossrefType "journal-article" @default.
• W2025183670 hasAuthorship W2025183670A5002007061 @default.
• W2025183670 hasAuthorship W2025183670A5004784482 @default.
• W2025183670 hasAuthorship W2025183670A5040757935 @default.
• W2025183670 hasAuthorship W2025183670A5075966979 @default.
• W2025183670 hasAuthorship W2025183670A5077613549 @default.
• W2025183670 hasAuthorship W2025183670A5077824195 @default.
• W2025183670 hasAuthorship W2025183670A5082697782 @default.
• W2025183670 hasConcept C118552586 @default.
• W2025183670 hasConcept C126322002 @default.
• W2025183670 hasConcept C2776376669 @default.
• W2025183670 hasConcept C2776814716 @default.
• W2025183670 hasConcept C2777080012 @default.
• W2025183670 hasConcept C2778000748 @default.
• W2025183670 hasConcept C2781302539 @default.
• W2025183670 hasConcept C42219234 @default.
• W2025183670 hasConcept C558461103 @default.
• W2025183670 hasConcept C71924100 @default.
• W2025183670 hasConceptScore W2025183670C118552586 @default.
• W2025183670 hasConceptScore W2025183670C126322002 @default.
• W2025183670 hasConceptScore W2025183670C2776376669 @default.
• W2025183670 hasConceptScore W2025183670C2776814716 @default.
• W2025183670 hasConceptScore W2025183670C2777080012 @default.
• W2025183670 hasConceptScore W2025183670C2778000748 @default.
• W2025183670 hasConceptScore W2025183670C2781302539 @default.
• W2025183670 hasConceptScore W2025183670C42219234 @default.
• W2025183670 hasConceptScore W2025183670C558461103 @default.
• W2025183670 hasConceptScore W2025183670C71924100 @default.
• W2025183670 hasIssue "3" @default.
• W2025183670 hasLocation W20251836701 @default.
• W2025183670 hasLocation W20251836702 @default.
• W2025183670 hasOpenAccess W2025183670 @default.
• W2025183670 hasPrimaryLocation W20251836701 @default.
• W2025183670 hasRelatedWork W1566969599 @default.
• W2025183670 hasRelatedWork W2141855023 @default.
• W2025183670 hasRelatedWork W2270077230 @default.
• W2025183670 hasRelatedWork W2348523392 @default.
• W2025183670 hasRelatedWork W2361312777 @default.
• W2025183670 hasRelatedWork W2937808830 @default.
• W2025183670 hasRelatedWork W3030442507 @default.

• next